Cite
HARVARD Citation
Yi, H. et al. (2020). Bcl‐2/Bcl‐xl inhibitor APG‐1252‐M1 is a promising therapeutic strategy for gastric carcinoma. Cancer medicine. pp. 4197-4206. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yi, H. et al. (2020). Bcl‐2/Bcl‐xl inhibitor APG‐1252‐M1 is a promising therapeutic strategy for gastric carcinoma. Cancer medicine. pp. 4197-4206. [Online].